These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 34182755)
1. Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases. Tehrani KHME; Wade N; Mashayekhi V; Brüchle NC; Jespers W; Voskuil K; Pesce D; van Haren MJ; van Westen GJP; Martin NI J Med Chem; 2021 Jul; 64(13):9141-9151. PubMed ID: 34182755 [TBL] [Abstract][Full Text] [Related]
2. Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance. van Haren MJ; Tehrani KHME; Kotsogianni I; Wade N; Brüchle NC; Mashayekhi V; Martin NI Chemistry; 2021 Feb; 27(11):3806-3811. PubMed ID: 33237604 [TBL] [Abstract][Full Text] [Related]
3. H Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873 [TBL] [Abstract][Full Text] [Related]
4. A Cephalosporin-Tripodalamine Conjugate Inhibits Metallo-β-Lactamase with High Efficacy and Low Toxicity. Tian H; Wang Y; Dai Y; Mao A; Zhou W; Cao X; Deng H; Lu H; Ding L; Shen H; Wang X Antimicrob Agents Chemother; 2022 Oct; 66(10):e0035222. PubMed ID: 36094199 [TBL] [Abstract][Full Text] [Related]
5. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors. Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors. Shaaban MM; Ragab HM; Akaji K; McGeary RP; Bekhit AA; Hussein WM; Kurz JL; Elwakil BH; Bekhit SA; Ibrahim TM; Mahran MA; Bekhit AA Bioorg Chem; 2020 Dec; 105():104386. PubMed ID: 33137556 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1. Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264 [TBL] [Abstract][Full Text] [Related]
9. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases. Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and investigation of inhibitory activities of imidazole derivatives against the metallo-β-lactamase IMP-1. Khalili Arjomandi O; Kavoosi M; Adibi H Bioorg Chem; 2019 Nov; 92():103277. PubMed ID: 31539743 [TBL] [Abstract][Full Text] [Related]
11. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem. Tehrani KHME; Martin NI ACS Infect Dis; 2017 Oct; 3(10):711-717. PubMed ID: 28820574 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*. Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956 [TBL] [Abstract][Full Text] [Related]
13. NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases. Zhang E; Wang MM; Huang SC; Xu SM; Cui DY; Bo YL; Bai PY; Hua YG; Xiao CL; Qin S Bioorg Med Chem Lett; 2018 Jan; 28(2):214-221. PubMed ID: 29248295 [TBL] [Abstract][Full Text] [Related]
14. Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases. Li JQ; Gao H; Zhai L; Sun LY; Chen C; Chigan JZ; Ding HH; Yang KW Bioorg Med Chem; 2021 May; 38():116128. PubMed ID: 33862468 [TBL] [Abstract][Full Text] [Related]
15. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors. Yan YH; Li W; Chen W; Li C; Zhu KR; Deng J; Dai QQ; Yang LL; Wang Z; Li GB Eur J Med Chem; 2022 Jan; 228():113965. PubMed ID: 34763944 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and enzyme-based evaluation of analogues Khalili Arjomandi O; Kavoosi M; Adibi H J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1414-1425. PubMed ID: 31401901 [TBL] [Abstract][Full Text] [Related]
17. Progress toward inhibitors of metallo-β-lactamases. McGeary RP; Tan DT; Schenk G Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895 [TBL] [Abstract][Full Text] [Related]
18. Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases. Proschak A; Martinelli G; Frank D; Rotter MJ; Brunst S; Weizel L; Burgers LD; Fürst R; Proschak E; Sosič I; Gobec S; Wichelhaus TA Eur J Med Chem; 2022 Jan; 228():113975. PubMed ID: 34865870 [TBL] [Abstract][Full Text] [Related]
19. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance. Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y mBio; 2020 Mar; 11(2):. PubMed ID: 32184250 [TBL] [Abstract][Full Text] [Related]
20. Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases. Pan X; He Y; Chen T; Chan KF; Zhao Y Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]